Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ABBV

3 High-Quality Stocks to Buy Hand Over Fist These Days

Even after inflation showed signs of cooling, fears of a recession continue to linger on investors. Despite having a muddled outlook of the market ahead, many experts believe there is still room for optimism. Given this backdrop, fundamentally sound high-quality stocks AbbVie (ABBV), Cisco Systems (CSCO), and Hugo Boss (BOSSY)…

StockNews.com

3 Top Pharma Stocks to Buy for the Long Haul

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

StockNews.com

3 Safe High-Dividend Stocks to Buy Right Now

While inflation pressures seem to be cooling, the Fed is expected to continue with its rate hikes, raising the chances of a recession this year. Hence, high-dividend stocks AbbVie (ABBV), Gilead Sciences (GILD), and Marine Products (MPX) might be solid buys for steady income amid current uncertainties. Keep reading.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

The #1 Pharma Stock to Buy in January 2023

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on….

StockNews.com

3 Safe Dividend Stocks to Buy Today and Hold Forever

Amid diminishing inflationary pressures, rate hikes are expected to slow down. However, the Fed might continue with the rate hikes. As a recession looks imminent, we think fundamentally sound dividend stocks AbbVie (ABBV), Marine Products (MPX), and Bassett Furniture Industries (BSET) might be ideal buy-and-hold options to ensure a steady…

StockNews.com

3 Stocks to Buy Right Now for the Long Term

Although inflation slowed further in December, concerns of a recession weigh heavy on investors’ sentiments as the Fed plans to continue raising interest rates this year. Amid this backdrop, investors could consider buying fundamentally strong stocks AbbVie (ABBV), The Coca-Cola Company (KO), and Centene Corporation (CNC) for the long-term. Read…

StockNews.com

3 Blue-Chip Stocks to Make Sure You Own in 2023

Despite the ever-expanding list of tech layoffs due to macroeconomic headwinds, a few fundamentally strong businesses are well-positioned to maintain their growth trajectory in the foreseeable future. Therefore, loading up on stocks of three such wonderful businesses, AbbVie (ABBV), Broadcom (AVGO), and Verizon (VZ), available at fair prices, could set…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 High-Quality Stocks That Can Help Take Your Portfolio to the Next Level

With encouraging economic data discouraging investors, the market is unlikely to stabilize anytime soon. Therefore, loading up on fundamentally strong stocks AbbVie (ABBV), Gartner (IT), and Dropbox (DBX) could keep portfolios buoyant and generate alpha in an otherwise chronic bear market. Continue reading….

StockNews.com

2 Health Care Stocks You Can't Go Wrong with Buying Right Now

Government funding for the healthcare industry is increasing significantly. Additionally, progressions in hospitals’ digital architecture and a surge in telemedicine brought on by the convergence of the COVID-19 pandemic and 5G networks are further boosting the industry’s growth. Hence, investing in fundamentally strong healthcare stocks AbbVie (ABBV) and Cardinal Health…

StockNews.com

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

4 Warren Buffett Stocks to Buy and Never Sell

Legendary investor Warren Buffett’s holding company Berkshire Hathaway has outperformed the broader market over the past year. His investment portfolio has been a guide for several long-term investors for decades. Amid a highly uncertain market and economic backdrop, Warren Buffett holdings Procter & Gamble (PG), AbbVie (ABBV), Biogen (BIIB), and…

StockNews.com

3 High-Yield Dividend Stocks to Buy Now to Retire Rich

Even though inflation seems to be cooling down, the Fed expects the interest rate hikes to continue in the near term. As market volatility is expected to remain, high-yielding dividend stocks AbbVie (ABBV), Sisecam Resources (SIRE), and Bassett Furniture (BSET) could be wise buys now. These stocks could help you…

StockNews.com

3 Stocks You Shouldn't Wait Any Longer to Buy

With slowing inflation, indications of slower rate hikes by the Fed beginning this month, and resilient employment growth, fundamentally strong stocks AbbVie (ABBV), Oracle Corporation (ORCL), and McKesson (MCK) could be opportune investments now. Continue reading….

StockNews.com

2 Top Medical Stocks to Buy and Hold for the Long Term

While the stock market has been under pressure this year, medical stocks have remained resilient due to the inelastic demand for their offerings. Moreover, the demand for medical goods and services is rising amid increasing health awareness and chronic diseases. Given the solid prospects of the industry, fundamentally sound medical…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income

The stock market has experienced wild swings this year amid the Fed’s battle to curb the multi-decade high inflation levels with its stringent interest rate hikes. This has raised recession fears, and many economists now foresee an economic downturn. Amid the market turbulence, investors could buy dividend aristocrats AbbVie (ABBV),…

StockNews.com

3 Bold Stocks to Buy Hand Over Fist Right Now

While the impact of further rate hikes has been majorly factored into the stock market, it could be wise to invest in fundamentally sound stocks AbbVie (ABBV), AT&T (T), and Molina Healthcare (MOH) to tide over any possible the turbulences. Continue reading….

StockNews.com

3 Stocks You Won't Regret Buying in December 2022

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY).…

StockNews.com

5 Stocks Investors Can Hold Onto Forever

Although the stock market remains highly volatile due to high inflation levels and the Fed’s aggressive monetary policy stance, analysts believe consumer prices will significantly decline in 2023. Moreover, the Fed also signaled slower rate hikes ahead. So, fundamentally strong stocks, AbbVie (ABBV), CSX Corporation (CSX), Waste Management (WM), Stellantis…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

2 Strong Health Care Stocks to Add to Your Portfolio Now

The global healthcare industry is showing robust growth prospects with the growing adoption of advanced technologies, rising health awareness, and increasing chronic diseases. Amid rising spending on medicines, fundamentally strong healthcare stocks AbbVie (ABBV) and Bristol-Myers Squibb (BMY) might be ideal additions to your portfolio now. Read on.

StockNews.com

1 No-Brainer Stock to Buy That Could Help You Retire Earlier

Biopharma giant AbbVie (ABBV) is well-placed to gain from its drug pipeline, recent drug approvals, and strategic acquisitions. Given its strong fundamentals, discounted valuation, high profitability, reliable dividends, and favorable analyst estimates, investing in this stock could help you retire earlier. Read more.

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

Benzinga

AbbVie Unusual Options Activity For October 28

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

Benzinga

This Is What Whales Are Betting On AbbVie

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

1 … 6 7 8 9

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.